Notice of NICHD Participation in RFA-AI-20-078 "Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)"
Notice Number:
NOT-HD-21-030

Key Dates

Release Date:

May 3, 2021

Related Announcements

RFA-AI-20-078 - Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)

Issued by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

This Notice announces the participation of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in RFA-AI-20-078" Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)", effective immediately.

The following sections of RFA-AI-20-078 have been modified (changes shown in bold italics) to reflect the participation of NICHD in this Funding Opportunity Announcement (FOA):

Part 1. Overview Information

Components of Participating Organizations

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Environmental Health Sciences (NIEHS)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
 

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.855; 93.113, 93.865

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Sai P. Majji, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-402-8048
Email: sai.majji@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices